Publications

• What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric Malignancies.
  Pediatr Blood Cancer Page(s): e31744
  04/20/2025 Authors: Taylor ZL; Miller TP; Board SG; Poweleit EA; Chavana A; Weisnicht A; Brown AL; Bernhardt MB; Schafer ES; O'Brien MM
• Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions.
  Pediatr Blood Cancer Volume: 72 Page(s): e31532
  03/01/2025 Authors: Slatnick LR; Hoogstra D; Fisher BT; Wolf J; Orgel E; Nessle CN; Patel PA; Miller TP; Wilkes J; Dupuis LL
• Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
  N Engl J Med Volume: 392 Page(s): 875 - 891
  02/27/2025 Authors: Gupta S; Rau RE; Kairalla JA; Rabin KR; Wang C; Angiolillo AL; Alexander S; Carroll AJ; Conway S; Gore L
• Erratum: Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR.
  JCO Clin Cancer Inform Volume: 9 Page(s): e2500013
  02/01/2025 Authors: Miller TP; Getz KD; Krause E; Jo YG; Charapala S; Gramatges MM; Rabin K; Scheurer ME; Wilkes JJ; Fisher BT
• Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR.
  JCO Clin Cancer Inform Volume: 8 Page(s): e2400100
  11/01/2024 Authors: Miller TP; Getz KD; Krause E; Jo YG; Charapala S; Gramatages MM; Rabin K; Scheurer ME; Wilkes JJ; Fisher BT
• Toxicity profile of high-dose methotrexate in young children with central nervous system tumors.
  Pediatr Blood Cancer Volume: 71 Page(s): e31213
  10/01/2024 Authors: Chavana AN; Taylor ZL; DeGroote N; Lindsay HB; Sauer HE; Mason EJ; Schafer ES; Miller TP; Castellino SM; Pommert L
• Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards.
  JCO Oncol Pract Volume: 20 Page(s): 1314 - 1330
  10/01/2024 Authors: Siegel RD; LeFebvre KB; Temin S; Evers A; Barbarotta L; Bowman RM; Chan A; Dougherty DW; Ganio M; Hunter B
• Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies.
  Pediatr Transplant Volume: 28 Page(s): e14750
  05/01/2024 Authors: Fisher BT; Blumenstock J; Boge CLK; Shuster S; Seif AE; Green M; Michaels MG; Alexander JL; Ardura MI; Miller TP
• An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia.
  J Clin Med Volume: 13
  03/20/2024 Authors: Al-Hussaini I; White B; Varmeziar A; Mehra N; Sanchez M; Lee J; DeGroote NP; Miller TP; Mitchell CS
• Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
  J Clin Oncol Volume: 42 Page(s): 832 - 841
  03/01/2024 Authors: Zhao Z; Patel PA; Slatnick L; Sitthi-Amorn A; Bielamowicz KJ; Nunez FA; Walsh AM; Hess J; Rossoff J; Elgarten C
• Missing the mark? Exploratory analysis of the 10-year-old cutoff as an independent marker of high-risk disease in pediatric B-ALL.
  Pediatr Blood Cancer Volume: 71 Page(s): e30825
  03/01/2024 Authors: George PE; DeGroote NP; Henderson M; Jordan K; Ziworitin-Ogola C; Castellino SM; Miller TP
• Applying machine learning to identify pediatric patients with newly diagnosed acute lymphoblastic leukemia using administrative data.
  Pediatr Blood Cancer Volume: 71 Page(s): e30858
  03/01/2024 Authors: Cao L; Huang Y-S; Getz KD; Seif AE; Ruiz J; Miller TP; Fisher BT; Aplenc R; Li Y
• Racial and ethnic disparities in acuity of presentation among children with newly diagnosed acute leukemia.
  Pediatr Blood Cancer Volume: 71 Page(s): e30726
  01/01/2024 Authors: Winestone LE; Getz KD; Li Y; Burrows E; Scheurer ME; Tam V; Gramatges MM; Wilkes JJ; Miller TP; Seif AE
• Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment.
  Hematology Am Soc Hematol Educ Program Volume: 2023 Page(s): 581 - 586
  12/08/2023 Authors: Janardan SK; Miller TP
• Acute and chronic kidney injury during therapy for pediatric acute leukemia: A report from the Leukemia Electronic Abstraction of Records Network (LEARN).
  Pediatr Blood Cancer Volume: 70 Page(s): e30696
  12/01/2023 Authors: Hsiao W; Li Y; Getz K; Cao L; Krause E; Ramos M; Lee J; Gramatges MM; Rabin KR; Scheurer ME
• Supportive Care in Pediatric Oncology: Opportunities and Future Directions.
  Cancers (Basel) Volume: 15
  11/23/2023 Authors: Freedman JL; Beeler DM; Bowers A; Bradford N; Cheung YT; Davies M; Dupuis LL; Elgarten CW; Jones TM; Jubelirer T
• Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
  Clin Transl Sci Volume: 16 Page(s): 2130 - 2143
  11/01/2023 Authors: Taylor ZL; Miller TP; Poweleit EA; DeGroote NP; Pommert L; Awoniyi O; Board SG; Ugboh N; Joshi V; Ambrosino N
• High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma.
  Pediatr Blood Cancer Volume: 70 Page(s): e30571
  11/01/2023 Authors: Summers RJ; Monroig VM; DeGroote NP; West ZE; Katafias E; Miller TP
• Children's Oncology Group's 2023 blueprint for research: Cancer control and supportive care.
  Pediatr Blood Cancer Volume: 70 Suppl 6 Page(s): e30568
  09/01/2023 Authors: Esbenshade AJ; Sung L; Brackett J; Dupuis LL; Fisher BT; Grimes A; Miller TP; Ullrich NJ; Dvorak CC; Cancer Control and Supportive Care Committee
• SARS-CoV-2 infections in patients enrolled on the Children's Oncology Group standard-risk B-cell acute lymphoblastic leukemia trial, AALL1731.
  EJHaem Volume: 4 Page(s): 745 - 750
  08/01/2023 Authors: Elgarten CW; Kairalla JA; Thompson JC; Miller TP; Wang C; Conway S; Loh ML; Raetz EA; Gupta S; Rau RE
• HEMOGLOBIN A1C AND ASSOCIATION WITH TOXICITIES DURING INDUCTION FOR ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 70 Page(s): S54 - S55
  06/01/2023 Authors: Miller T; Strange L; DeGroote N; Henderson M; Bernardo S; Chukoian L; Clegg E; Lahey A; Schlesinger J; Wang P
• ASSOCIATION BETWEEN ADVERSE EVENTS AND END OF INDUCTION MINIMAL RESIDUAL DISEASE IN PEDIATRIC ALL
  Volume: 70 Page(s): S51 - S52
  06/01/2023 Authors: Henderson M; DeGroote N; Ziworitin-Ogola C; Lau C; Jordan K; Byers E; West Z; Castellino S; Miller T
• Leveraging machine learning to identify acute myeloid leukemia patients and their chemotherapy regimens in an administrative database.
  Pediatr Blood Cancer Volume: 70 Page(s): e30260
  05/01/2023 Authors: Cao L; Huang Y-S; Wu C; Getz K; Miller TP; Ruiz J; Fisher BT; Seif AE; Aplenc R; Li Y
• Preventable harm because of outpatient medication errors among children with leukemia and lymphoma: A multisite longitudinal assessment.
  Cancer Volume: 129 Page(s): 1064 - 1074
  04/01/2023 Authors: Wong CI; Vannatta K; Gilleland Marchak J; Quade EV; Rodgers IM; Reid CM; Dandoy CE; Billett AL; Miller TP; Vaughn S
• Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
  Cancer Volume: 129 Page(s): 780 - 789
  03/01/2023 Authors: Afify ZAM; Taj MM; Orjuela-Grimm M; Srivatsa K; Miller TP; Edington HJ; Dalal M; Robles J; Ford JB; Ehrhardt MJ
• Data standards in pediatric oncology: Past, present, and future.
  Pediatr Blood Cancer Volume: 70 Page(s): e30128
  02/01/2023 Authors: Wyatt KD; Noyd DH; Wood NM; Phillips CA; Miller TP; Rubin EM; Winestone LE; Waanders AJ; Perentesis JP; Aplenc R
• Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.
  Br J Haematol Volume: 200 Page(s): 297 - 305
  02/01/2023 Authors: Afify Z; Orjuela-Grimm M; Smith CM; Dalal M; Ford JB; Pillai P; Robles JM; Reddy S; McCormack S; Ehrhardt MJ
• Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
  J Natl Cancer Inst Volume: 115 Page(s): 21 - 28
  01/10/2023 Authors: Roth ME; Parsons SK; Ganz PA; Wagner LI; Hinds PS; Alexander S; Bingen K; Bober SL; Brackett J; Cella D
• Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components.
  Cancer Rep (Hoboken) Volume: 6 Page(s): e1665
  01/01/2023 Authors: Stevenson J; DeGroote NP; Keller F; Brock KE; Bergsagel DJ; Miller TP; Cornwell P; Fasano R; Chonat S; Castellino SM
• Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
  Pediatr Blood Cancer Volume: 70 Page(s): e30062
  01/01/2023 Authors: Molina JC; Li Y; Otto WR; Miller TP; Getz KD; Mccoubrey C; Ramos M; Krause E; Cao L; Gramatges MM
• Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
  Cancer Volume: 128 Page(s): 4129 - 4138
  12/01/2022 Authors: Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
• Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.
  Pediatr Blood Cancer Volume: 69 Page(s): e29937
  11/01/2022 Authors: Elgarten CW; Thompson JC; Angiolillo A; Chen Z; Conway S; Devidas M; Gupta S; Kairalla JA; McNeer JL; O'Brien MM
• Automated Ascertainment of Typhlitis From the Electronic Health Record.
  JCO Clin Cancer Inform Volume: 6 Page(s): e2200081
  09/01/2022 Authors: Miller TP; Li Y; Masino AJ; Vallee E; Burrows E; Ramos M; Alonzo TA; Gerbing R; Castellino SM; Hawkins DS
• Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
  Lancet Haematol Volume: 9 Page(s): e678 - e688
  09/01/2022 Authors: Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH
• DIAGNOSIS AND MANAGEMENT OF TYPHLITIS IN PEDIATRIC LEUKEMIA PATIENTS
  Volume: 69
  06/01/2022 Authors: Vallee E; DeGroote N; Ziworitin-Ogola C; Monroig V; Ruiz FC; Ramos M; Grundmeier R; Aplenc R; Miller T
• TRAJECTORY OF HYPERGLYCEMIA IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
  Volume: 69
  06/01/2022 Authors: Lederer S; DeGroote N; Josh V; West Z; Castellino S; Miller T
• SIGNIFICANT BURDEN OF ADVERSE EVENTS DURING THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Summers R; Monroig V; DeGroote N; West Z; Katafias E; Castellino S; Miller T
• COMPLICATIONS BY CENTRAL LINE TYPE DURING INDUCTION CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 69
  06/01/2022 Authors: Degroote N; Joshi V; West Z; Bathina N; Castellino S; Miller T
• AUTOMATED ELECTRONIC HEALTH RECORD ASCERTAINMENT OF TYPHLITIS: A CHILDREN'S ONCOLOGY GROUP REPORT
  Volume: 69
  06/01/2022 Authors: Miller TP; Li Y; Masino A; Vallee E; Burrows E; Castellino S; Hawkins D; Ramos M; Lash T; Aplenc R
• Incidence and risk factors for hypoglycemia during maintenance chemotherapy in pediatric acute lymphoblastic leukemia.
  Pediatr Blood Cancer Volume: 69 Page(s): e29467
  06/01/2022 Authors: Rosenfeld E; Getz KD; Miller TP; Seif AE; Fisher BT; Burrows E; Ramos MJ; De Len DD; Aplenc R; Morales KH
• A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment.
  Haematologica Volume: 107 Page(s): 1185 - 1188
  05/01/2022 Authors: Yi JS; Chambers TM; Getz KD; Miller TP; Burrows E; Daves MH; Lupo PJ; Scheurer ME; Aplenc R; Rabin KR
• Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report.
  J Patient Saf Volume: 18 Page(s): e672 - e679
  04/01/2022 Authors: Miller TP; Marx MZ; Henchen C; DeGroote NP; Jones S; Weiland J; Fisher B; Esbenshade AJ; Aplenc R; Dvorak CC
• Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment.
  Pediatr Blood Cancer Volume: 68 Page(s): e28315
  09/01/2021 Authors: Cahen VC; Li Y; Getz KD; Elgarten CW; DiNofia AM; Wilkes JJ; Winestone LE; Huang Y-SV; Miller TP; Gramatges MM
• Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia.
  Pediatr Blood Cancer Volume: 68 Page(s): e28940
  07/01/2021 Authors: Ibrahimova A; Winestone LE; Miller TP; Kettler K; Seif AE; Huang Y-S; Elgarten CW; Myers RM; Fisher BT; Aplenc R
• PREDICTORS AND OUTCOMES OF IMMUNOGLOBULIN SUPPLEMENTATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 68 Page(s): S53 - S53
  06/01/2021 Authors: Edington H; DeGroote N; Miller T; Stevenson J; Chandrakasan S; Mertens A; Castellino S
• CHARACTERISTICS AND OUTCOMES OF PEDIATRIC ONCOLOGY PATIENTS AT RISK FOR TRANSFUSION REFUSAL
  Volume: 68 Page(s): S97 - S98
  06/01/2021 Authors: Stevenson J; DeGroote N; Choudhury T; Keller F; Brock K; Bergsagel DJ; Miller T; Cornwell P; Chonat S; Castellino S
• Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.
  Curr Hematol Malig Rep Volume: 16 Page(s): 126 - 131
  04/01/2021 Authors: Miller TP; Aplenc R
• Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.
  Leuk Lymphoma Volume: 62 Page(s): 899 - 908
  04/01/2021 Authors: West ZE; Castellino SM; Monroe C; Thomas AS; McCracken C; Miller TP
• Improving symptom control and reducing toxicities for pediatric patients with hematological malignancies.
  Hematology Am Soc Hematol Educ Program Volume: 2020 Page(s): 280 - 286
  12/04/2020 Authors: Sung L; Miller TP; Phillips R
• Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever
  Volume: 136
  11/05/2020 Authors: Patel PA; DeGroote NP; Esbenshade AJ; Cash WT; Castellino SM; Jaggi P; Miller TP
• Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
  Pediatr Blood Cancer Volume: 67 Page(s): e28570
  11/01/2020 Authors: Shinn K; Wetzel M; DeGroote NP; Keller F; Briones M; Felker J; Castellino S; Miller TP
• LEARN-ING ABOUT DURATION OF NEUTROPENIA IN ACUTE MYELOID LEUKEMIA
  Volume: 67 Page(s): S168 - S168
  06/01/2020 Authors: Miller TP; Getz K; Demissei B; Rabin K; Daves M; Lupo P; Scheurer M; Burrows E; Fisher B; Grundmeier R
• Feasibility and acceptability of an animatronic duck intervention for promoting adaptation to the in-patient setting among pediatric patients receiving treatment for cancer.
  Pediatr Blood Cancer Volume: 66 Page(s): e27984
  12/01/2019 Authors: Miller TP; Klosky JL; Zamora F; Swift M; Mertens AC
• Adverse Events during Induction Therapy in Pediatric Acute Lymphoblastic Lymphoma (ALL)
  Volume: 134
  11/13/2019 Authors: West Z; Allen K; Monroe C; Castellino SM; Miller TP
• Rates of Laboratory Adverse Events By Chemotherapy Course for Pediatric Acute Leukemia Patients within the Leukemia Electronic Abstraction of Records Network (LEARN)
  Volume: 134
  11/13/2019 Authors: Miller TP; Getz KD; Demissei B; Rabin KR; Daves M; Lupo PJ; Scheurer ME; Burrows E; Fisher BT; Grundmeier RW
• Transient Elevations in Markers of Hepatic Function during Pediatric Acute Lymphoblastic Leukemia Treatment Are Common but Do Not Influence Outcomes: A Study of 805 Patients from the Learn Consortium
  Volume: 134
  11/13/2019 Authors: Yi JS; Chambers T; Getz KD; Miller TP; Burrows E; Daves M; Lupo PJ; Scheurer ME; Aplenc R; Rabin KR
• Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events.
  Pediatr Blood Cancer Volume: 66 Page(s): e27747
  07/01/2019 Authors: Miller TP; Fisher BT; Getz KD; Sack L; Razzaghi H; Seif AE; Bagatell R; Adamson PC; Aplenc R
• CLINICAL VALUE OF RESPIRATORY VIRAL PANEL IN PEDIATRIC PATIENTS WITH CANCER AND FEBRILE NEUTROPENIA
  Volume: 66
  06/01/2019 Authors: Shinn K; Wetzel M; Keller F; Briones M; Felker J; Miller T
• Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia
  Volume: 132
  11/29/2018 Authors: Winestone LE; Getz KD; Li Y; Burrows E; Scheurer M; Gramatges MM; Wilkes JJ; Miller TP; Seif AE; Grundmeier RW
• Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia.
  Pediatr Crit Care Med Volume: 19 Page(s): e312 - e320
  06/01/2018 Authors: Fitzgerald JC; Li Y; Fisher BT; Huang Y-S; Miller TP; Bagatell R; Seif AE; Aplenc R; Thomas NJ
• Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia.
  PLoS One Volume: 13 Page(s): e0192529
  01/01/2018 Authors: Getz KD; Miller TP; Seif AE; Li Y; Huang Y-SV; Fisher BT; Aplenc R
• Complications preceding early deaths in Black and White children with acute myeloid leukemia.
  Pediatr Blood Cancer Volume: 64
  12/01/2017 Authors: Winestone LE; Getz KD; Miller TP; Li Y; Huang Y-S; Seif AE; Fisher BT; Aplenc R
• Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
  Cancer Volume: 123 Page(s): 3781 - 3790
  10/01/2017 Authors: Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A
• Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
  Haematologica Volume: 102 Page(s): e340 - e343
  09/01/2017 Authors: Miller TP; Li Y; Kavcic M; Getz KD; Huang Y-SV; Sung L; Alonzo TA; Gerbing R; Daves MH; Horton TM
• Using electronic medical record data to report laboratory adverse events.
  Br J Haematol Volume: 177 Page(s): 283 - 286
  04/01/2017 Authors: Miller TP; Li Y; Getz KD; Dudley J; Burrows E; Pennington J; Ibrahimova A; Fisher BT; Bagatell R; Seif AE
• Reply to H.S.L. Jim et al.
  J Clin Oncol Volume: 35 Page(s): 1135
  04/01/2017 Authors: Miller TP; Aplenc R
• The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia.
  Am J Hematol Volume: 92 Page(s): 141 - 148
  02/01/2017 Authors: Winestone LE; Getz KD; Miller TP; Wilkes JJ; Sack L; Li Y; Huang Y-S; Seif AE; Bagatell R; Fisher BT
• Low rates of pregnancy screening in adolescents before teratogenic exposures in a national sample of children's hospitals.
  Cancer Volume: 122 Page(s): 3394 - 3400
  11/15/2016 Authors: Rao P; Li Y; Getz KD; Miller TP; Huang Y-S; Wilkes JJ; Seif AE; Bagatell R; Fisher BT; Gracia C
• Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report.
  Cancer Med Volume: 5 Page(s): 2412 - 2416
  09/01/2016 Authors: Getz KD; Miller TP; Seif AE; Li Y; Huang Y-S; Alonzo T; Gerbing R; Sung L; Hall M; Bagatell R
• A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
  Leuk Lymphoma Volume: 57 Page(s): 1567 - 1574
  07/01/2016 Authors: Miller TP; Getz KD; Kavcic M; Li Y; Huang Y-SV; Sung L; Alonzo TA; Gerbing R; Daves M; Horton TM
• Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia.
  J Clin Oncol Volume: 34 Page(s): 1537 - 1543
  05/01/2016 Authors: Miller TP; Li Y; Kavcic M; Troxel AB; Huang Y-SV; Sung L; Alonzo TA; Gerbing R; Hall M; Daves MH
• Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
  Pediatr Blood Cancer Volume: 62 Page(s): 1775 - 1781
  10/01/2015 Authors: Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang Y-S; Arnold S; Seif AE; Miller TP
• A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
  Cancer Med Volume: 4 Page(s): 1356 - 1364
  09/01/2015 Authors: Getz KD; Miller TP; Seif AE; Li Y; Huang Y-S; Bagatell R; Fisher BT; Aplenc R
• Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.
  Pediatr Blood Cancer Volume: 62 Page(s): 1184 - 1189
  07/01/2015 Authors: Miller TP; Troxel AB; Li Y; Huang Y-S; Alonzo TA; Gerbing RB; Hall M; Torp K; Fisher BT; Bagatell R
• Accuracy of adverse event reporting on a phase III clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group.
  Volume: 33
  05/20/2015 Authors: Miller TP; Li Y; Kavcic M; Alonzo TA; Hall M; Huang Y-S; Gerbing RB; Fisher B; Luger SM; Rubin D
• Comparison of Resource Utilization in Children Discharged Versus Children That Remain Hospitalized Following Chemotherapy for Acute Myeloid Leukemia
  Volume: 124
  12/06/2014 Authors: Getz KD; Miller TP; Seif AE; Li Y; Huang Y-S; Bagatell R; Fisher BT; Aplenc R
• Patient Factors Associated with Enrollment on an Acute Myeloid Leukemia Phase III Clinical Trial: A Report from the Children's Oncology Group
  Volume: 124
  12/06/2014 Authors: Rao P; Li Y; Alonzo TA; Sung L; Gerbing RB; Getz KD; Seif AE; Miller TP; Huang Y-S; Bagatell R
• Accuracy Of Adverse Event Reporting Compared To Patient Chart Abstraction On a Phase III NCI-Funded Clinical Trial For Pediatric Acute Myeloid Leukemia: A Report From The Children's Oncology Group
  Volume: 122
  11/15/2013 Authors: Miller TP; Kavcic M; Li Y; Alonzo TA; Hall M; Huang Y-S; Gerbing RB; Fisher BT; Luger S; Rubin D
• Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.
  Pediatr Blood Cancer Volume: 57 Page(s): 492 - 498
  09/01/2011 Authors: Mrakotsky CM; Silverman LB; Dahlberg SE; Alyman MCA; Sands SA; Queally JT; Miller TP; Cranston A; Neuberg DS; Sallan SE
• Sec5, a member of the exocyst complex, mediates Drosophila embryo cellularization.
  Development Volume: 137 Page(s): 2773 - 2783
  08/01/2010 Authors: Murthy M; Teodoro RO; Miller TP; Schwarz TL